{"transactions":[{"id":710575,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-13T20:05:10.000Z","date":"2026-07-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":44000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated May 1, 2026, by and among the Issuer, Essence Parent Inc., a Delaware corporation (\"Parent\") and Essence MergerCo Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"MergerCo\"), pursuant to which, on July 13, 2026 (the \"Effective Time\"), MergerCo merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."}],"balance_after":0,"derivative":{"exercise_price":0.87,"expiration_date":"2035-05-29","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001628280-26-048007","document":"wk-form4_1783973106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828026048007/wk-form4_1783973106.xml","form_type":"4"}},{"id":710574,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-13T20:05:10.000Z","date":"2026-07-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":32500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated May 1, 2026, by and among the Issuer, Essence Parent Inc., a Delaware corporation (\"Parent\") and Essence MergerCo Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"MergerCo\"), pursuant to which, on July 13, 2026 (the \"Effective Time\"), MergerCo merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."}],"balance_after":0,"derivative":{"exercise_price":2.25,"expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001628280-26-048007","document":"wk-form4_1783973106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828026048007/wk-form4_1783973106.xml","form_type":"4"}},{"id":710573,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-13T20:05:10.000Z","date":"2026-07-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":21000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated May 1, 2026, by and among the Issuer, Essence Parent Inc., a Delaware corporation (\"Parent\") and Essence MergerCo Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"MergerCo\"), pursuant to which, on July 13, 2026 (the \"Effective Time\"), MergerCo merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."}],"balance_after":0,"derivative":{"exercise_price":1.37,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001628280-26-048007","document":"wk-form4_1783973106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828026048007/wk-form4_1783973106.xml","form_type":"4"}},{"id":710572,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-13T20:05:10.000Z","date":"2026-07-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":141023,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated May 1, 2026, by and among the Issuer, Essence Parent Inc., a Delaware corporation (\"Parent\") and Essence MergerCo Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"MergerCo\"), pursuant to which, on July 13, 2026 (the \"Effective Time\"), MergerCo merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent."},{"field":"shares","element":"transactionShares","label":"F2","text":"At the Effective Time, each share of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") was converted into the right to receive (a) an amount in cash equal to $3.16 per share, without interest (the \"per share cash consideration\"), and (b) one contractual contingent value right per share (each, a \"CVR\" and, together with the per share cash consideration, the \"merger consideration\"), representing the right to participate in contingent payments in cash, without interest, upon the achievement of certain milestones, subject to any applicable withholding taxes. From and after the Effective Time, all such shares of Common Stock were no longer outstanding and were automatically canceled."},{"field":"shares","element":"transactionShares","label":"F3","text":"Includes 79,873 restricted stock units (each, a \"RSU\"). At the Effective Time, each RSU with respect to Common Stock outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested), and was canceled and converted into the right to receive, with respect to each share of Common Stock subject to such RSU immediately prior to the effective time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the per share cash consideration, plus (b) one CVR, subject to certain exceptions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each share of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") was converted into the right to receive (a) an amount in cash equal to $3.16 per share, without interest (the \"per share cash consideration\"), and (b) one contractual contingent value right per share (each, a \"CVR\" and, together with the per share cash consideration, the \"merger consideration\"), representing the right to participate in contingent payments in cash, without interest, upon the achievement of certain milestones, subject to any applicable withholding taxes. From and after the Effective Time, all such shares of Common Stock were no longer outstanding and were automatically canceled."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Includes 79,873 restricted stock units (each, a \"RSU\"). At the Effective Time, each RSU with respect to Common Stock outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested), and was canceled and converted into the right to receive, with respect to each share of Common Stock subject to such RSU immediately prior to the effective time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the per share cash consideration, plus (b) one CVR, subject to certain exceptions."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001628280-26-048007","document":"wk-form4_1783973106.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828026048007/wk-form4_1783973106.xml","form_type":"4"}},{"id":739306,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-12T20:15:24.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":77000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2026, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":77000,"derivative":{"exercise_price":1.22,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":77000},"source":{"system":"sec-edgar","filing":"0001573553-26-000002","document":"form4-06122026_040605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000157355326000002/form4-06122026_040605.xml","form_type":"4"}},{"id":756935,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-01T20:23:15.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":79873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The awards vest in full on the earlier of (i) May 28, 2027 and (ii) the Issuer's next annual meeting of stockholders following May 28, 2026."}],"balance_after":141023,"source":{"system":"sec-edgar","filing":"0001628280-26-039523","document":"wk-form4_1780345393.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828026039523/wk-form4_1780345393.xml","form_type":"4"}},{"id":1112966,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-12T20:19:06.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2025, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.75,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-25-016930","document":"form4-06122025_040605.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925016930/form4-06122025_040605.xml","form_type":"4"}},{"id":1127515,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-02T20:10:13.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The awards vest in full on the earlier of (i) May 29, 2026 and (ii) the Issuer's next annual meeting of stockholders following May 29, 2025."}],"balance_after":44000,"derivative":{"exercise_price":0.87,"expiration_date":"2035-05-29","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001628280-25-028829","document":"wk-form4_1748895006.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828025028829/wk-form4_1748895006.xml","form_type":"4"}},{"id":1127514,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-02T20:10:13.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The awards vest in full on the earlier of (i) May 29, 2026 and (ii) the Issuer's next annual meeting of stockholders following May 29, 2025."}],"balance_after":61150,"source":{"system":"sec-edgar","filing":"0001628280-25-028829","document":"wk-form4_1748895006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828025028829/wk-form4_1748895006.xml","form_type":"4"}},{"id":1273673,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T09:19:21.000Z","date":"2025-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":6.92,"expiration_date":"2026-09-06","underlying":"Common Stock","underlying_shares":3850},"source":{"system":"sec-edgar","filing":"0001104659-25-011247","document":"tm255946-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465925011247/tm255946-9_4seq1.xml","form_type":"4"}},{"id":1273672,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T09:19:21.000Z","date":"2025-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":4.84,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":2625},"source":{"system":"sec-edgar","filing":"0001104659-25-011247","document":"tm255946-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465925011247/tm255946-9_4seq1.xml","form_type":"4"}},{"id":1273671,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T09:19:21.000Z","date":"2025-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":24.76,"expiration_date":"2027-12-06","underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001104659-25-011247","document":"tm255946-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465925011247/tm255946-9_4seq1.xml","form_type":"4"}},{"id":1273670,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T09:19:21.000Z","date":"2025-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":15.84,"expiration_date":"2029-02-26","underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001104659-25-011247","document":"tm255946-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465925011247/tm255946-9_4seq1.xml","form_type":"4"}},{"id":1273669,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T09:19:21.000Z","date":"2025-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":8.28,"expiration_date":"2030-01-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-25-011247","document":"tm255946-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465925011247/tm255946-9_4seq1.xml","form_type":"4"}},{"id":1273668,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T09:19:21.000Z","date":"2025-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":12.6,"expiration_date":"2031-01-15","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001104659-25-011247","document":"tm255946-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465925011247/tm255946-9_4seq1.xml","form_type":"4"}},{"id":1273667,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T09:19:21.000Z","date":"2025-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":10.4,"expiration_date":"2032-02-04","underlying":"Common Stock","underlying_shares":12375},"source":{"system":"sec-edgar","filing":"0001104659-25-011247","document":"tm255946-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465925011247/tm255946-9_4seq1.xml","form_type":"4"}},{"id":1273666,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T09:19:21.000Z","date":"2025-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":5.94,"expiration_date":"2033-01-26","underlying":"Common Stock","underlying_shares":16200},"source":{"system":"sec-edgar","filing":"0001104659-25-011247","document":"tm255946-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465925011247/tm255946-9_4seq1.xml","form_type":"4"}},{"id":1273665,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T09:19:21.000Z","date":"2025-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":9.74,"expiration_date":"2034-01-18","underlying":"Common Stock","underlying_shares":20900},"source":{"system":"sec-edgar","filing":"0001104659-25-011247","document":"tm255946-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465925011247/tm255946-9_4seq1.xml","form_type":"4"}},{"id":1273664,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T09:19:21.000Z","date":"2025-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each outstanding out-of-the-money stock option (i.e., a stock option that has an exercise price per share that is greater than the Offer Price) was terminated and the Reporting Person was not entitled to any payment in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":1.4,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":10450},"source":{"system":"sec-edgar","filing":"0001104659-25-011247","document":"tm255946-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465925011247/tm255946-9_4seq1.xml","form_type":"4"}},{"id":1273663,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-11T09:19:21.000Z","date":"2025-02-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2300,"price":0.55,"value":1265.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 29, 2024, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Immedica Pharma AB, a corporation organized and existing under the laws of Sweden (\"Parent\"), and Matador Subsidiary, Inc. a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $0.55 per share (the \"Offer Price\") in cash."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents 2,300 shares underlying Restricted Stock Units (the \"RSUs\"). Pursuant to the terms of the Merger Agreement, at the effective time of the merger (the \"Effective Time\"), each outstanding RSU was terminated in exchange for a lump sum cash payment equal to (i) the Offer Price multiplied by (ii) the number of shares of Common Stock underlying the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 29, 2024, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Immedica Pharma AB, a corporation organized and existing under the laws of Sweden (\"Parent\"), and Matador Subsidiary, Inc. a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $0.55 per share (the \"Offer Price\") in cash."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-25-011247","document":"tm255946-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465925011247/tm255946-9_4seq1.xml","form_type":"4"}},{"id":1273662,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-11T09:19:21.000Z","date":"2025-02-07","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12707,"price":0.55,"value":6988.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On December 29, 2024, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Immedica Pharma AB, a corporation organized and existing under the laws of Sweden (\"Parent\"), and Matador Subsidiary, Inc. a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $0.55 per share (the \"Offer Price\") in cash."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On December 29, 2024, the Issuer entered into an Agreement and Plan of Merger (the \"Merger Agreement\") with Immedica Pharma AB, a corporation organized and existing under the laws of Sweden (\"Parent\"), and Matador Subsidiary, Inc. a Delaware corporation and a wholly owned subsidiary of Parent (\"Purchaser\"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the \"Common Stock\") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $0.55 per share (the \"Offer Price\") in cash."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported amount reflects an adjustment to correct a clerical error that previously underreported the Reporting Person's holdings by 2,081 shares of Common Stock. No reportable transactions were omitted from previous filings in connection with the clerical error underlying this correction."}],"balance_after":2300,"source":{"system":"sec-edgar","filing":"0001104659-25-011247","document":"tm255946-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465925011247/tm255946-9_4seq1.xml","form_type":"4"}},{"id":1419771,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-29T20:15:13.000Z","date":"2024-08-28","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on September 28, 2024, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":1.45,"expiration_date":"2034-08-28","underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001415889-24-022533","document":"form4-08292024_040804.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588924022533/form4-08292024_040804.xml","form_type":"4"}},{"id":1423152,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-26T17:32:06.000Z","date":"2024-08-26","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":976,"price":1.52,"value":1483.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Upon the consummation of the merger (the \"Merger\") pursuant to that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of June 25, 2024, by and among Agile Therapeutics, Inc. (the \"Company\"), Insud Pharma, S.L. (\"Insud\"), and Exeltis Project, Inc., a Delaware corporation and indirect, wholly owned subsidiary of Insud (\"Merger Sub\"), 976 shares of Common Stock were converted into the right to receive into the right to receive a cash payment of $1.52 (the \"Merger Consideration\") per share of Common Stock, for an aggregate of $1,484, equal to the product of (x) the Merger Consideration, multiplied by (y) the total number of shares of Common Stock owned by the reporting person"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-24-092936","document":"tm2422466-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465924092936/tm2422466-2_4seq1.xml","form_type":"4"}},{"id":1472970,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-20T16:24:22.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":10450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in full on July 15, 2025, subject to the reporting person's continued service with the Issuer."}],"balance_after":10450,"derivative":{"exercise_price":1.4,"expiration_date":"2034-06-18","underlying":"Common Stock","underlying_shares":10450},"source":{"system":"sec-edgar","filing":"0001415889-24-017635","document":"form4-06202024_080618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000141588924017635/form4-06202024_080618.xml","form_type":"4"}},{"id":1472969,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-20T16:24:22.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":2300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (RSUs). The RSUs vest in full on July 15, 2025, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer."}],"balance_after":12926,"source":{"system":"sec-edgar","filing":"0001415889-24-017635","document":"form4-06202024_080618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000141588924017635/form4-06202024_080618.xml","form_type":"4"}},{"id":1501848,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-24T20:18:01.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The awards vest in full on the earlier of (i) May 23, 2025 and (ii) the Issuer's next annual meeting of stockholders following May 23, 2024."}],"balance_after":32500,"derivative":{"exercise_price":2.25,"expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001628280-24-025221","document":"wk-form4_1716581864.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828024025221/wk-form4_1716581864.xml","form_type":"4"}},{"id":1501847,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-24T20:18:01.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The awards vest in full on the earlier of (i) May 23, 2025 and (ii) the Issuer's next annual meeting of stockholders following May 23, 2024."}],"balance_after":28150,"source":{"system":"sec-edgar","filing":"0001628280-24-025221","document":"wk-form4_1716581864.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828024025221/wk-form4_1716581864.xml","form_type":"4"}},{"id":1675086,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-19T16:25:05.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":20900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in 12 equal monthly installments beginning on February 18, 2024, subject to the reporting person's continued service with the Issuer."}],"balance_after":20900,"derivative":{"exercise_price":9.74,"expiration_date":"2034-01-18","underlying":"Common Stock","underlying_shares":20900},"source":{"system":"sec-edgar","filing":"0001415889-24-001598","document":"form4-01192024_090158.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000141588924001598/form4-01192024_090158.xml","form_type":"4"}},{"id":1675085,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-19T16:25:05.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":4600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (RSUs). The RSUs vest in full on January 18, 2025, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer."}],"balance_after":10626,"source":{"system":"sec-edgar","filing":"0001415889-24-001598","document":"form4-01192024_090158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000141588924001598/form4-01192024_090158.xml","form_type":"4"}},{"id":1819772,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-01T17:09:57.000Z","date":"2023-07-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Stock options of the Issuer (the \"Company Options\") were canceled in the merger and (i) if the Company Option had an exercise price less than the Upfront Consideration, it was exchanged for (1) common stock of the Acquiror with a value equal to the quotient of (A) the product of (x) the total number of common stock of Issuer underlying the Company Option multiplied by (y) the excess, if any, of the value of the Upfront Consideration over the exercise price of such Company Option, divided by (B) the average of the daily volume-weighted average price per share of the common stock of Acquiror calculated based on the ten (10) consecutive trading days ending two trading days prior to the date of the Merger Agreement and (2) a number of CVRs equal to the number of shares of common stock of the Issuer underlying such Company Option, (ii) if the Company Option had an exercise price equal to or greater than the Upfront Consideration and less than the Merger Consideration,"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"(Continued from Footnote 2) it was exchanged for a number of CVRs equal to the number of common stock of the Issuer underlying such Company Option (reduced by the amount that the exercise price exceeds the Upfront Consideration) and (iii) if the Company Option had an exercise price equal to or greater than the Merger Consideration, it was canceled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options of the Issuer (the \"Company Options\") were canceled in the merger and (i) if the Company Option had an exercise price less than the Upfront Consideration, it was exchanged for (1) common stock of the Acquiror with a value equal to the quotient of (A) the product of (x) the total number of common stock of Issuer underlying the Company Option multiplied by (y) the excess, if any, of the value of the Upfront Consideration over the exercise price of such Company Option, divided by (B) the average of the daily volume-weighted average price per share of the common stock of Acquiror calculated based on the ten (10) consecutive trading days ending two trading days prior to the date of the Merger Agreement and (2) a number of CVRs equal to the number of shares of common stock of the Issuer underlying such Company Option, (ii) if the Company Option had an exercise price equal to or greater than the Upfront Consideration and less than the Merger Consideration,"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"(Continued from Footnote 2) it was exchanged for a number of CVRs equal to the number of common stock of the Issuer underlying such Company Option (reduced by the amount that the exercise price exceeds the Upfront Consideration) and (iii) if the Company Option had an exercise price equal to or greater than the Merger Consideration, it was canceled for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Stock options of the Issuer (the \"Company Options\") were canceled in the merger and (i) if the Company Option had an exercise price less than the Upfront Consideration, it was exchanged for (1) common stock of the Acquiror with a value equal to the quotient of (A) the product of (x) the total number of common stock of Issuer underlying the Company Option multiplied by (y) the excess, if any, of the value of the Upfront Consideration over the exercise price of such Company Option, divided by (B) the average of the daily volume-weighted average price per share of the common stock of Acquiror calculated based on the ten (10) consecutive trading days ending two trading days prior to the date of the Merger Agreement and (2) a number of CVRs equal to the number of shares of common stock of the Issuer underlying such Company Option, (ii) if the Company Option had an exercise price equal to or greater than the Upfront Consideration and less than the Merger Consideration,"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"(Continued from Footnote 2) it was exchanged for a number of CVRs equal to the number of common stock of the Issuer underlying such Company Option (reduced by the amount that the exercise price exceeds the Upfront Consideration) and (iii) if the Company Option had an exercise price equal to or greater than the Merger Consideration, it was canceled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":1.13,"underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000899243-23-017672","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000089924323017672/doc4.xml","form_type":"4"}},{"id":1819771,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2023-08-01T17:09:57.000Z","date":"2023-07-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":54066,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Issuer disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 24, 2023, by and among the Issuer, Assertio Holdings, Inc., a Delaware corporation (\"Acquiror\"), and Spade Merger Sub 1, Inc., a Delaware corporation and a wholly owned subsidiary of Acquiror, in exchange for consideration of (a) 0.1783 of a share of the common stock of Acquiror and cash in lieu of fractional shares (the \"Upfront Consideration\") and (b) a contingent value right (\"CVR\") to receive up to an additional $0.20 per common share (subject to adjustment), payable in cash or common stock of Acquiror at the election of Acquiror, upon the achievement of certain milestones, (the Upfront Consideration plus one CVR, collectively, the \"Merger Consideration\") on the effective date of the merger."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-017672","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000089924323017672/doc4.xml","form_type":"4"}},{"id":1851956,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T20:08:41.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The awards vest in full on the earlier of (i) June 15, 2024 and (ii) the Issuer's next annual meeting of stockholders following June 15, 2023."}],"balance_after":21000,"derivative":{"exercise_price":1.37,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001628280-23-022458","document":"wf-form4_168694610673749.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828023022458/wf-form4_168694610673749.xml","form_type":"4"}},{"id":1851955,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:08:41.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":5150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The awards vest in full on the earlier of (i) June 15, 2024 and (ii) the Issuer's next annual meeting of stockholders following June 15, 2023."}],"balance_after":5150,"source":{"system":"sec-edgar","filing":"0001628280-23-022458","document":"wf-form4_168694610673749.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828023022458/wf-form4_168694610673749.xml","form_type":"4"}},{"id":1860144,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-09T20:20:34.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 7, 2023, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":3.86,"expiration_date":"2033-06-07","underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-23-035825","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919123035825/doc4.xml","form_type":"4"}},{"id":1860335,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-09T17:12:07.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":1065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 8, 2023 and vests in full on June 8, 2024, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":1065,"derivative":{"exercise_price":3.58,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":1065},"source":{"system":"sec-edgar","filing":"0000929638-23-001712","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000092963823001712/form4.xml","form_type":"4"}},{"id":1860334,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-09T17:12:07.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units that were granted on June 8, 2023, which will vest and be settled in common stock on June 8, 2024, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On April 10, 2023 the Issuer completed a one-for-fifty reverse stock split of the Issuer's common stock. This amount has been adjusted to give effect to this reverse stock split."}],"balance_after":976,"source":{"system":"sec-edgar","filing":"0000929638-23-001712","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000092963823001712/form4.xml","form_type":"4"}},{"id":1940009,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-23T23:33:36.000Z","date":"2023-03-21","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in equal monthly installments, beginning on April 21, 2023, over a period of three years, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":42000,"derivative":{"exercise_price":3.45,"expiration_date":"2033-03-21","underlying":"Common Shares","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001209191-23-020844","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919123020844/doc4.xml","form_type":"4"}},{"id":2026340,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-08T16:37:47.000Z","date":"2023-02-06","kind":"sale","acquired":false,"shares":1018,"price":6.54,"value":6657.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares of common stock of Marinus Pharmaceuticals, Inc. (the \"Company\") sold by the reporting person pursuant to a Rule 10b5-1 plan to cover tax obligations in connection with the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $6.54 - $6.55, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":6026,"source":{"system":"sec-edgar","filing":"0001415889-23-002163","document":"form4-02082023_090232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000141588923002163/form4-02082023_090232.xml","form_type":"4"}},{"id":2042031,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-30T16:24:48.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":16200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in 12 equal monthly installments beginning on February 26, 2023, subject to the reporting person's continued service with the Issuer."}],"balance_after":16200,"derivative":{"exercise_price":5.94,"expiration_date":"2033-01-26","underlying":"Common Stock","underlying_shares":16200},"source":{"system":"sec-edgar","filing":"0001415889-23-001556","document":"form4-01302023_090138.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000141588923001556/form4-01302023_090138.xml","form_type":"4"}},{"id":2042030,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-30T16:24:48.000Z","date":"2023-01-26","kind":"grant","acquired":true,"shares":3600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (RSUs). The RSUs vest in full on January 26, 2024, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer."}],"balance_after":7044,"source":{"system":"sec-edgar","filing":"0001415889-23-001556","document":"form4-01302023_090138.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000141588923001556/form4-01302023_090138.xml","form_type":"4"}},{"id":2168322,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-02T16:33:19.000Z","date":"2022-08-31","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One third of the aggregate amount of option shares shall vest on each of August 31, 2023, 2024 and 2025, respectively."}],"balance_after":75000,"derivative":{"exercise_price":1.13,"expiration_date":"2032-08-31","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-22-048515","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919122048515/doc4.xml","form_type":"4"}},{"id":2168321,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2022-09-02T16:33:19.000Z","date":"2022-08-31","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") granted on August 31, 2022. One hundred percent (100%) of the total number of RSUs granted vest on the earlier of (i) June 22, 2023 or (ii) the date of the Company's 2023 Annual Meeting of Stockholders."}],"balance_after":54066,"source":{"system":"sec-edgar","filing":"0001209191-22-048515","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919122048515/doc4.xml","form_type":"4"}},{"id":2224658,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2022-06-22T21:55:17.000Z","date":"2022-06-21","kind":"sale","acquired":false,"shares":5711,"price":0.785,"value":4483.135,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer."}],"balance_after":29066,"source":{"system":"sec-edgar","filing":"0001209191-22-038810","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919122038810/doc4.xml","form_type":"4"}},{"id":2235700,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-06-10T16:47:55.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 9, 2022 and vests in full on June 9, 2023, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":807,"derivative":{"exercise_price":1.22,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":807},"source":{"system":"sec-edgar","filing":"0001104659-22-070181","document":"tm2218213-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465922070181/tm2218213-5_4seq1.xml","form_type":"4"}},{"id":2235699,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-10T16:47:55.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units that were granted on June 9, 2022, which will vest and be settled in common stock on June 9, 2023, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On April 26, 2022, the Issuer completed a one-for-forty reverse stock split of the Issuer's common stock. This amount has been adjusted to give effect to this reverse stock split."}],"balance_after":2066,"source":{"system":"sec-edgar","filing":"0001104659-22-070181","document":"tm2218213-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465922070181/tm2218213-5_4seq1.xml","form_type":"4"}},{"id":2253246,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy","published_at":"2022-05-27T20:19:21.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":11561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The awards vest in full on the earlier of (i) May 26, 2023 and (ii) the Issuer's next annual meeting of stockholders following May 26, 2022."}],"balance_after":11561,"derivative":{"exercise_price":5.51,"expiration_date":"2032-05-26","underlying":"Common Stock","underlying_shares":11561},"source":{"system":"sec-edgar","filing":"0001628280-22-015591","document":"wf-form4_165368271040719.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828022015591/wf-form4_165368271040719.xml","form_type":"4"}},{"id":2409971,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-07T16:10:33.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":12375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in 12 equal monthly installments beginning on March 4, 2022."}],"balance_after":12375,"derivative":{"exercise_price":10.4,"expiration_date":"2032-02-04","underlying":"Common Stock","underlying_shares":12375},"source":{"system":"sec-edgar","filing":"0001104659-22-012784","document":"tm225605-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465922012784/tm225605-6_4seq1.xml","form_type":"4"}},{"id":2409970,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-07T16:10:33.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":2750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (RSUs). The RSUs vest in full on February 4, 2023, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer."}],"balance_after":3444,"source":{"system":"sec-edgar","filing":"0001104659-22-012784","document":"tm225605-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465922012784/tm225605-6_4seq1.xml","form_type":"4"}},{"id":2659656,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-22T17:18:07.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":67804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One third of the aggregate amount of option shares shall vest on each of June 17, 2022, 2023 and 2024, respectively."}],"balance_after":67804,"derivative":{"exercise_price":4.29,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":67804},"source":{"system":"sec-edgar","filing":"0001209191-21-042453","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919121042453/doc4.xml","form_type":"4"}},{"id":2659655,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2021-06-22T17:18:07.000Z","date":"2021-06-18","kind":"sale","acquired":false,"shares":12000,"price":4.24,"value":50880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer."}],"balance_after":34777,"source":{"system":"sec-edgar","filing":"0001209191-21-042453","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919121042453/doc4.xml","form_type":"4"}},{"id":2659654,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2021-06-22T17:18:07.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":14277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the restricted shares shall vest on the earlier of (1) June 17, 2022 or (2) the date of the company's 2022 Annual Meeting of Stockholders."}],"balance_after":46777,"source":{"system":"sec-edgar","filing":"0001209191-21-042453","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919121042453/doc4.xml","form_type":"4"}},{"id":2673689,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-06-10T19:13:13.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":29905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on June 8, 2021 and vests in full on June 8, 2022, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":29905,"derivative":{"exercise_price":1.53,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":29905},"source":{"system":"sec-edgar","filing":"0001104659-21-079621","document":"tm2119345-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465921079621/tm2119345-4_4seq1.xml","form_type":"4"}},{"id":2673688,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-10T19:13:13.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":24510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units that were granted on June 8, 2021, which will vest and be settled in common stock on June 8, 2022, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":55852,"source":{"system":"sec-edgar","filing":"0001104659-21-079621","document":"tm2119345-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465921079621/tm2119345-4_4seq1.xml","form_type":"4"}},{"id":2904118,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-01-19T20:12:36.000Z","date":"2021-01-15","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase shares of common stock vest in 12 equal monthly installments, commencing on 1/31/21."}],"balance_after":16500,"derivative":{"exercise_price":12.6,"expiration_date":"2031-01-15","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001104659-21-005518","document":"tm213599-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465921005518/tm213599-4_4seq1.xml","form_type":"4"}},{"id":3104781,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T17:49:15.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One third of the aggregate amount of option shares shall vest on each of June 18, 2021, 2022 and 2023, respectively."}],"balance_after":60000,"derivative":{"exercise_price":2.94,"expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-20-038021","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919120038021/doc4.xml","form_type":"4"}},{"id":3104780,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2020-06-19T17:49:15.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the restricted shares shall vest on the earlier of (1) June 18, 2021 or (2) the date of the company's 2021 Annual Meeting of Stockholders."}],"balance_after":32500,"source":{"system":"sec-edgar","filing":"0001209191-20-038021","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919120038021/doc4.xml","form_type":"4"}},{"id":3113252,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-06-11T17:22:25.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":22606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on June 9, 2020 and vests in full on June 9, 2021, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":22606,"derivative":{"exercise_price":2.8,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":22606},"source":{"system":"sec-edgar","filing":"0001104659-20-072489","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465920072489/a4.xml","form_type":"4"}},{"id":3113251,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-11T17:22:25.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":13393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units that were granted on June 9, 2020, which will vest and be settled in common stock on June 9, 2021, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":31342,"source":{"system":"sec-edgar","filing":"0001104659-20-072489","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465920072489/a4.xml","form_type":"4"}},{"id":3169573,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-27T18:33:35.000Z","date":"2020-04-23","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the option shares vested on April 23, 2020.  The remaining option shares shall vest in equal amounts of 25% of the total shares underlying the option shares on each anniversary of the grant date over the next three years."}],"balance_after":5000,"derivative":{"exercise_price":2.79,"expiration_date":"2030-04-23","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-20-025873","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919120025873/doc4.xml","form_type":"4"}},{"id":3169572,"issuer":{"id":111009,"kind":"organization","name":"SPECTRUM PHARMACEUTICALS INC","symbol":"SPPI"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2020-04-27T18:33:35.000Z","date":"2020-04-23","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the restricted shares shall vest on June 18, 2020."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001209191-20-025873","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/831547/000120919120025873/doc4.xml","form_type":"4"}},{"id":3313192,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-01-10T16:52:57.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase shares of common stock vest in 12 equal monthly installments, commencing on 1/31/20."}],"balance_after":100000,"derivative":{"exercise_price":2.07,"expiration_date":"2030-01-08","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-20-003098","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465920003098/a4.xml","form_type":"4"}},{"id":3496925,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-06-07T16:31:54.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 6, 2019 and vests in full on June 6, 2020, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":75000,"derivative":{"exercise_price":1.03,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001104659-19-034553","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465919034553/a4.xml","form_type":"4"}},{"id":3625979,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-02-28T18:59:17.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"5,833 options to purchase shares of common stock vest immediately on 2/26/19.  The remainder vest in 10 equal monthly installments commencing 3/1/19."}],"balance_after":35000,"derivative":{"exercise_price":3.96,"expiration_date":"2029-02-26","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-19-011638","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465919011638/a4.xml","form_type":"4"}},{"id":3769277,"issuer":{"id":1816,"kind":"organization","name":"Streamex Corp.","symbol":"STEX"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-10T01:15:48.000Z","date":"2018-10-16","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On September 10, 2018, BioSig Technologies, Inc. effected a 1-for-2.5 reverse stock split (the \"Stock Split\"). The number of shares reported have been adjusted for the Stock Split."}],"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001185185-18-001972","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518518001972/ownership.xml","form_type":"4"}},{"id":3899778,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-06-08T17:03:01.000Z","date":"2018-06-08","kind":"exercise","acquired":false,"shares":17949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 8, 2017, the Reporting Person was granted 17,949 restricted stock units, vesting in full on June 8, 2018, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attended at least 75% of the board meetings held during the year of board service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 8, 2017, the Reporting Person was granted 17,949 restricted stock units, vesting in full on June 8, 2018, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attended at least 75% of the board meetings held during the year of board service."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17949},"source":{"system":"sec-edgar","filing":"0001104659-18-039222","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465918039222/a4.xml","form_type":"4"}},{"id":3899777,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-06-08T17:03:01.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on June 7, 2018 and vests in full on June 7, 2019, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":50000,"derivative":{"exercise_price":0.6,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-18-039222","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465918039222/a4.xml","form_type":"4"}},{"id":3899776,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T17:03:01.000Z","date":"2018-06-08","kind":"exercise","acquired":true,"shares":17949,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":17949,"source":{"system":"sec-edgar","filing":"0001104659-18-039222","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465918039222/a4.xml","form_type":"4"}},{"id":4114675,"issuer":{"id":151460,"kind":"organization","name":"VIVUS INC","symbol":"VVUS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Consultant"}}],"security":"Common Stock","published_at":"2018-01-03T19:11:29.000Z","date":"2018-01-01","kind":"disposition_to_issuer","acquired":false,"shares":2102,"price":0.5,"value":1051.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than by way of forfeiture to VIVUS, Inc. in order to cover estimated tax liability."}],"balance_after":633978,"source":{"system":"sec-edgar","filing":"0001123292-18-000035","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/881524/000112329218000035/edgar.xml","form_type":"4"}},{"id":4137764,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2017-12-08T16:05:56.000Z","date":"2017-12-06","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase shares of common stock vest in 12 equal monthly installments commencing 1/1/18."}],"balance_after":35000,"derivative":{"exercise_price":6.19,"expiration_date":"2027-12-06","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-17-072519","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465917072519/a4.xml","form_type":"4"}},{"id":4286844,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-06-09T17:03:30.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":17949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on June 8, 2017 and vest in full on June 8, 2018, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on June 8, 2017 and vest in full on June 8, 2018, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":17949,"derivative":{"underlying":"Common Stock","underlying_shares":17949},"source":{"system":"sec-edgar","filing":"0001104659-17-038462","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465917038462/a4.xml","form_type":"4"}},{"id":4286843,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-06-09T17:03:30.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 8, 2017 and vests in full on June 8, 2018, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":14000,"derivative":{"exercise_price":3.9,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001104659-17-038462","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465917038462/a4.xml","form_type":"4"}},{"id":4475985,"issuer":{"id":151460,"kind":"organization","name":"VIVUS INC","symbol":"VVUS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-01-31T18:45:38.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-five percent (25%) of the total number of shares underlying the option will vest and become exercisable on January 27, 2018, and one forty-eighth (1/48th) of the total number of shares underlying the option will vest on the 27th of each month thereafter, subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2010 Equity Incentive Plan) on the relevant vesting dates."}],"balance_after":1000000,"derivative":{"exercise_price":1.12,"expiration_date":"2024-01-27","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001123292-17-000302","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/881524/000112329217000302/edgar.xml","form_type":"4"}},{"id":4475984,"issuer":{"id":151460,"kind":"organization","name":"VIVUS INC","symbol":"VVUS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-01-31T18:45:38.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of VIVUS, Inc. common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units vest according to the following schedule: twenty-five percent (25%) of the total restricted stock units vest on January 27, 2018 with an additional six and one quarter percent (6.25%) of the total restricted stock units vesting quarterly thereafter (i.e., April 27th, July 27th, October 27th, and January 27th) until all of the restricted stock units are vested, subject to such individual continuing to be a Service Provider (as defined in the Issuer's 2010 Equity Incentive Plan) on the relevant vesting dates."}],"balance_after":636080,"source":{"system":"sec-edgar","filing":"0001123292-17-000302","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/881524/000112329217000302/edgar.xml","form_type":"4"}},{"id":4486357,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock","published_at":"2017-01-19T17:19:31.000Z","date":"2017-01-17","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of restricted stock represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All shares of restricted stock vest on 1/17/18."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Not applicable."}],"balance_after":4500,"derivative":{"underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001104659-17-003116","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465917003116/a4.xml","form_type":"4"}},{"id":4486356,"issuer":{"id":83359,"kind":"organization","name":"MARINUS PHARMACEUTICALS, INC.","symbol":"MRNS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2017-01-19T17:19:31.000Z","date":"2017-01-17","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options to purchase shares of common stock vest in 12 equal monthly installments commencing 1/31/17."}],"balance_after":10500,"derivative":{"exercise_price":1.21,"expiration_date":"2027-01-17","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001104659-17-003116","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267813/000110465917003116/a4.xml","form_type":"4"}},{"id":4593731,"issuer":{"id":151460,"kind":"organization","name":"VIVUS INC","symbol":"VVUS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-09-28T18:25:58.000Z","date":"2016-01-22","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The original Form 4 for the transaction, filed on January 26, 2016, is being amended in connection with the terms of a Stock Option Acknowledgement entered into between VIVUS, Inc. and Mr. Fischer on September 26, 2016, whereby the portion of the original January 22, 2016 stock option grant, that was erroneously issued in excess of the limitations under the VIVUS, Inc. 2010 Equity Inventive Plan, was cancelled."},{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4 for the transaction, filed on January 26, 2016, is being amended in connection with the terms of a Stock Option Acknowledgement entered into between VIVUS, Inc. and Mr. Fischer on September 26, 2016, whereby the portion of the original January 22, 2016 stock option grant, that was erroneously issued in excess of the limitations under the VIVUS, Inc. 2010 Equity Inventive Plan, was cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the total number of shares underlying the option shall vest and become exercisable on January 22, 2017, and one forty-eighth (1/48th) of the total number of shares underlying the option will vest and become exercisable on the 22nd of each month thereafter, subject to such individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates."}],"balance_after":1000000,"derivative":{"exercise_price":1.06,"expiration_date":"2023-01-22","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001123292-16-002785","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/881524/000112329216002785/edgar.xml","form_type":"4/A","original_submission_date":"2016-01-26"}},{"id":4593730,"issuer":{"id":151460,"kind":"organization","name":"VIVUS INC","symbol":"VVUS"},"owners":[{"id":30803,"kind":"person","name":"Fischer Seth H. Z.","position":1,"cik":"0001573553","reported_name":"Fischer Seth H. Z.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2016-09-28T18:25:24.000Z","date":"2016-09-26","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of VIVUS, Inc. common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units vest according to the following schedule: 50% of the total restricted stock units vest on January 22, 2017 with an additional 12.5% of the total restricted stock units vesting on each of April 22, 2017, July 22, 2017, October 22, 2017 and January 22, 2018, subject to such individual continuing to be a Service Provider (as defined in the VIVUS, Inc. 2010 Equity Incentive Plan) on the relevant vesting dates."}],"balance_after":486080,"source":{"system":"sec-edgar","filing":"0001123292-16-002784","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/881524/000112329216002784/edgar.xml","form_type":"4"}}]}